The chief executive of San Diego-based magnetic source imaging developer Biomagnetic Technologies stepped down last month. James Schumacher, a GE Medical Systems veteran who led BTI since 1993, will be replaced as president and CEO by Scott Buchanan.
The chief executive of San Diego-based magnetic source imaging developer Biomagnetic Technologies stepped down last month. James Schumacher, a GE Medical Systems veteran who led BTI since 1993, will be replaced as president and CEO by Scott Buchanan. Schumacher remains on BTI's board, while the company's office of chairman will remain vacant.
The move was part of BTI's effort to cut costs by reducing management overhead, Schumacher said. BTI implemented a restructuring earlier this year after a delay in shipments of its Magnes 2500 Whole Head system resulted in a revenue shortfall (SCAN 2/5/97).
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.